Page last updated: 2024-08-24

isobutyramide and Prostatic Neoplasms

isobutyramide has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruchovsky, N; Gleave, ME; Sadar, M; Sato, N; Sullivan, L; Yago, V	1

Other Studies

1 other study(ies) available for isobutyramide and Prostatic Neoplasms

Article	Year
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model. Journal of cellular biochemistry, 1998, Jun-01, Volume: 69, Issue:3 Topics: Administration, Oral; Amides; Androgens; Animals; Antineoplastic Agents; Biological Availability; Cell Division; Gene Expression Regulation, Neoplastic; Half-Life; Humans; Male; Mice; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured	1998

Article

Year

Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.

Journal of cellular biochemistry, 1998, Jun-01, Volume: 69, Issue:3

Topics: Administration, Oral; Amides; Androgens; Animals; Antineoplastic Agents; Biological Availability; Cell Division; Gene Expression Regulation, Neoplastic; Half-Life; Humans; Male; Mice; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured

1998